Vedere Bio II Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vedere Bio II's estimated annual revenue is currently $1.4M per year.(i)
  • Vedere Bio II's estimated revenue per employee is $155,000

Employee Data

  • Vedere Bio II has 9 Employees.(i)
  • Vedere Bio II grew their employee count by -79% last year.

Vedere Bio II's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Vedere Bio II?

Vedere® is a stealth-stage company developing best-in-class genotype-agnostic gene therapies for vision restoration.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-79%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vedere Bio II News

2022-04-13 - Vedere Bio II Announces Appointment of Industry Veteran ...

Vedere Bio II Announces Appointment of Industry Veteran Gina Consylman as Chief Financial Officer. (PRNewsfoto/Vedere Bio, Inc.) News provided...

2022-04-13 - Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena ...

Prior to AskBio, Mansell was managing director and founder of White Oak BioPharma ... Vedere Bio II: Gina Consylman was named CFO of Vedere.

2022-04-06 - Belite Bio hits go on IPO to fund late-phase vision loss clinical ...

Belite Bio wants public investors to bankroll late-phase clinical trials of a ... Vedere Bio II has hired Gina Consylman as CFO to chart the financial...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M9N/AN/A
#3
$0.7M9-10%N/A
#4
$0.7M9-71%$138.8M
#5
$0.7M9-25%N/A